Frontiers20d
An analysis of the current status of geriatric oral disease treatment—a dental institutions-based perspective
Background: This study aimed to investigate and analyze the current status of oral disease treatment among the older adult in Guangxi Zhuang Autonomous Region, while also assessing the continuing ...
Nasdaq22d
Anavex Life Sciences Reports Positive Phase IIb/III Results for Blarcamesine as Novel Oral Treatment for Early Alzheimer’s Disease
Anavex Life Sciences Corp. announced that the Journal of Prevention of Alzheimer’s Disease published results from its Phase IIb/III study of blarcamesine (ANAVEX®2-73), an oral treatment for ...